广东省医药制造业产业竞争力研究

发布时间：2018-03-09 00:36

本文选题：广东省　切入点：医药制造业　出处：《广东药科大学》2017年硕士论文　论文类型：学位论文

【摘要】：医药制造业不单关系到国家的长远发展和人民的生命健康,而且是知识和技术密集型的高新技术产业,被世界公认为“朝阳产业”。在社会民生发展角度来看,人民的基本健康条件、优质药品、追求医疗保健要求的满足全有赖于医药制造业的发展,进而对我国人民生命安全和身体健康的权利形成了有力的保障。从社会经济发展角度来看,医药制造业不但是医药产业的主要组成成分,而且是我国经济的有机组成;促进医药制造业的发展能够促进更多人口就业、进出口贸易以及基建、技术投资的增加等,从而促进该地区乃至该国的经济发展。因此,研究我国区域医药制造业产业竞争力评价,合理地进行排名,了解广东省医药制造业发展现状及影响因素,提出合理的发展建议,这对促进广东省医药制造业产业竞争力的提升有重大的影响作用。本文依据已有的产业竞争力、医药制造业及其竞争力评价方法相关理论,对广东省医药制造业在全国各省市中的竞争力状况进行了定性、定量研究。首先,对我国及广东省医药制造业的产业发展现状进行了分析,内容主要包括我国医药制造业产业生产经营情况、扶持政策及影响及广东省医药制造业的产业发展状况、特点等。然后,在借鉴已有研究的基础上,科学、客观地构建医药制造业产业区域竞争力评价体系。接着,运用因子分析法对2010~2014年五年全国27个省市医药制造业相关指标的原始数据(内蒙古、西藏、青海和宁夏)进行实证分析,得出广东省医药制造业在全国的竞争力评价结论。结论为:通过广东省同其它省市比较,可得出广东省医药制造业综合竞争力稳居前列,具备相对较大优势,但距离绝对优势省市还有较大差距。另外,相关成分发展非常不均衡,投入效益及产品创新能力仅处于全国中游水平,是广东省医药制造业健康持续发展的严重障碍。最后,根据以上结论,从政府与企业两个角度对广东省今后医药制造业的发展提出了相关对策和建议。从政府方面,主要包括:大力发展医药产业集群规模,推动区域协调发展;优化产业扶持方式,增加资本投入渠道;壮大产业龙头企业,发挥区域药业品牌优势;深化对外合作,推动产业智能化发展;加强产业协同监管等措施。从企业方面,主要包括:调整产品结构,加强运营,提高获利能力;加大研发投入力度,提高研发创新能力;重视发展中医药现代化;自建或合办电商;向行业下游延伸等措施。
[Abstract]:The pharmaceutical manufacturing industry is not only related to the long-term development of the country and the life and health of the people, but also a knowledge-and technology-intensive high-tech industry, which is recognized as a "sunrise industry" by the world. From the perspective of social and livelihood development, The basic health conditions of the people, the quality of medicines, and the satisfaction of the medical and health care requirements all depend on the development of the pharmaceutical manufacturing industry. From the point of view of social and economic development, pharmaceutical manufacturing industry is not only the main component of the pharmaceutical industry, but also the organic component of our country's economy. Promoting the development of the pharmaceutical manufacturing industry can promote the employment of more people, import and export trade, as well as increased investment in infrastructure, technology, etc., thus promoting the economic development of the region and even the country. This paper studies the evaluation of the competitiveness of the regional pharmaceutical manufacturing industry in China, carries out a reasonable ranking, understands the current situation and influencing factors of the pharmaceutical manufacturing industry in Guangdong Province, and puts forward some reasonable suggestions for the development of the pharmaceutical manufacturing industry. This has a great influence on the promotion of the competitiveness of Guangdong pharmaceutical manufacturing industry. This paper based on the existing industrial competitiveness, pharmaceutical manufacturing industry and its competitiveness evaluation method related theory, In this paper, the competitiveness of pharmaceutical manufacturing industry in Guangdong Province is studied qualitatively and quantitatively. Firstly, the present situation of pharmaceutical manufacturing industry in China and Guangdong Province is analyzed. The contents mainly include the production and management of pharmaceutical manufacturing industry in China, the supporting policy and influence, and the industrial development and characteristics of pharmaceutical manufacturing industry in Guangdong Province. The evaluation system of regional competitiveness of pharmaceutical manufacturing industry is constructed objectively. Then, the raw data of pharmaceutical manufacturing related indexes in 27 provinces and cities of China from 2010 to 2014 are analyzed by factor analysis (Inner Mongolia, Tibet, Tibet, China). Through the empirical analysis of Qinghai and Ningxia), the conclusion is drawn that the comprehensive competitiveness of Guangdong pharmaceutical manufacturing industry is in the forefront through the comparison between Guangdong province and other provinces and cities, and the conclusion is: compared with other provinces and cities, the comprehensive competitiveness of Guangdong pharmaceutical manufacturing industry is in the forefront. With relatively large advantages, but there is still a big gap between the absolute advantage of provinces and cities. In addition, the development of related components is very uneven, investment efficiency and product innovation ability are only in the middle of the country. It is a serious obstacle to the healthy and sustainable development of the pharmaceutical manufacturing industry in Guangdong Province. Finally, according to the above conclusions, this paper puts forward some relevant countermeasures and suggestions for the future development of the pharmaceutical manufacturing industry in Guangdong Province from the two angles of the government and the enterprises. It mainly includes: vigorously developing the scale of pharmaceutical industry cluster, promoting regional coordinated development; optimizing industrial support mode and increasing capital input channels; expanding leading industrial enterprises, giving full play to regional pharmaceutical brand advantages; deepening foreign cooperation, Promote the intelligent development of industry, strengthen the industry coordination supervision and other measures. From the enterprise aspect, mainly include: adjust the product structure, strengthen the operation, improve the profit ability, increase the R & D investment, improve the R & D innovation ability; Attach importance to the development of modernization of Chinese medicine; self-establishment or co-operation of e-commerce; extension to the lower reaches of the industry and other measures.
【学位授予单位】：广东药科大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72;F271

【参考文献】